<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Hamburg_Composite_Part skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Hamburg/Composite Part</SPAN></H1><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="navmenu"><DIV id="navmenubox"><UL id="nav" class="col-md-10"><LI><A href="https://2015.igem.org/Team:Hamburg">HOME</A></LI><LI><A href="https://2015.igem.org/Team:Hamburg/Team">TEAM</A></LI><LI><A href="https://2015.igem.org/Team:Hamburg/Description">PROJECT</A></LI><LI><A class="liste" href="https://2015.igem.org/Team:Hamburg/Description">Overview</A></LI><LI><A class="liste" href="https://2015.igem.org/Team:Hamburg/Project/miRNA">microRNA 2911</A></LI><LI><A class="liste" href="https://2015.igem.org/Team:Hamburg/Project/PezT">Killgene PezT</A></LI><LI><A class="liste" href="https://2015.igem.org/Team:Hamburg/Experiments">Experiments &amp; Protocols</A></LI><LI><A class="liste" href="https://2015.igem.org/Team:Hamburg/Results">Results</A></LI></UL><LI><A href="https://2015.igem.org/Team:Hamburg/Parts">PARTS</A></LI><LI><A class="liste" href="https://2015.igem.org/Team:Hamburg/Parts">Team Parts</A></LI><LI><A class="liste" href="https://2015.igem.org/Team:Hamburg/Basic_Part">Basic Parts</A></LI><LI><A class="liste" href="https://2015.igem.org/Team:Hamburg/Composite_Part">Composite Parts</A></LI><LI><A href="https://2015.igem.org/Team:Hamburg/Notebook">NOTEBOOK</A></LI><LI><A href="https://2015.igem.org/Team:Hamburg/Attributions">ATTRIBUTIONS</A></LI><LI><A href="https://2015.igem.org/Team:Hamburg/Collaborations">COLLABORATIONS</A></LI><LI><A href="https://2015.igem.org/Team:Hamburg/Practices">HUMAN PRACTICES</A></LI><LI><A class="liste" href="https://2015.igem.org/Team:Hamburg/Practices/Seminar">Seminar</A></LI><LI><A class="liste" href="https://2015.igem.org/Team:Hamburg/Practices/Symposium">Symposium</A></LI><LI><A class="liste" href="https://2015.igem.org/Team:Hamburg/Practices/Risks">Risk Assessment</A></LI></DIV><LI><A href="https://2015.igem.org/Team:Hamburg/Safety">SAFETY</A></LI><LI><A href="https://2015.igem.org/Team:Hamburg/Modeling">MODELING</A></LI><LI><A class="liste" href="https://2015.igem.org/Team:Hamburg/Modeling/RNA">RNA</A></LI><LI><A class="liste" href="https://2015.igem.org/Team:Hamburg/Modeling/Networks">Networks</A></LI></DIV></DIV></DIV></DIV><DIV class="container" id="main"><H2> Composite Parts</H2><H3>constitutive promoter and miRNA</H3><P>Following our <A href="https://2015.igem.org/Team:Hamburg/Parts">ultimate goal</A> of a light-inducible expression system for the miRNA2911 (figure 1), we accomplished a constitutive expression system as an important intermediate step. It is a composite part of our basic part <A href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K1860700">miRNA2911</A> and the standard promotor <A href="http://parts.igem.org/wiki/index.php?title=Part:BBa_J23100">BBa_J23100</A> (figure 2).</P><FIGURE class="fig1"><FIGCAPTION>Fig. 1: Future BioBrick regarding our ultimate goal</FIGCAPTION></FIGURE><P><B>BioBrick state: </B>We submitted the <A href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K1860702">constitutive promoter and miRNA2911</A> biobrick to the registry. No sequencing validation was done yet, but an unspecific insert validation via colony PCR was successful.</P><FIGURE class="fig1"><FIGCAPTION>Fig. 2: Our BioBrick as an important intermediate step</FIGCAPTION></FIGURE><P><B>Sequence:</B> (<FONT color="orange">Prefix and Suffix</FONT>, <FONT color="red">3A assembly scar</FONT>, <FONT color="cyan">promoter</FONT>, miRNA)</P><P>5'</P><P><FONT face="courier"><FONT color="orange">GAATTCGCGGCCGCTTCTAGAG</FONT><FONT color="cyan">ttgacggctagctcagtcctaggtacagtgctagc</FONT><FONT color="red">TACTAGAG</FONT>GGCCGGGGGACGGACTGGGA<FONT color="orange">TACTAGTAGCGGCCGCTGCAG</FONT></FONT></P><P>3'</P><H3>GroEL promoter and blue Pigment</H3><P>Also for establishing a heat-inducible cell lysis system (GroEL and PezT, figure 3) we started to create an intermediate BioBrick for the validation of a GroEL heat induction ability. It is a composite part of our basic part <A href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K1860701">GroEL</A> and a blue pigment (<A href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K592009">BBa_J23100</A>) (figure 4). Future work would target a BioBrick of GroEL and PezT.</P><FIGURE class="fig1"><FIGCAPTION>Fig. 3: Future BioBrick regarding our ultimate goal</FIGCAPTION></FIGURE><P><B>BioBrick state: </B>We did <I>not</I> submit the <A href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K1860703">GroEL and blue pigment</A> biobrick to the registry. We just designed the sequence.</P><P><B>Sequence:</B> (<FONT color="orange">Prefix and Suffix</FONT>, <FONT color="red">3A assembly scar</FONT>, GroEL, <FONT color="green">RBS</FONT>, <FONT color="blue">Pribnow sequence</FONT>, <FONT color="cyan">blue pigment</FONT>)</P><P>5'</P><P><FONT face="courier"><FONT color="orange">GAATTCGCGGCCGCTTCTAGAG</FONT>CAGTTTCCCCCTTGAAGGGGCGAAGCCTCATCCCCATTT<FONT color="green">GAAGGAG</FONT><FONT color="blue">ATATTA</FONT><FONT color="red">TACTAGAG</FONT><FONT color="cyan">atgag tgtgatcgctaaacaaatgacctacaaggtttatatgtcaggcacggtcaatggacactactttgaggtcgaaggcgatggaaaagg taagccctacgagggggagcagacggtaaagctcactgtcaccaagggcggacctctgccatttgcttgggatattttatcaccaca gtgtcagtacggaagcataccattcaccaagtaccctgaagacatccctgactatgtaaagcagtcattcccggagggctatacatg ggagaggatcatgaactttgaagatggtgcagtgtgtactgtcagcaatgattccagcatccaaggcaactgtttcatctaccatgt caagttctctggtttgaactttcctcccaatggacctgtcatgcagaagaagacacagggctgggaacccaacactgagcgtctctt tgcacgagatggaatgctgctaggaaacaactttatggctctgaagttagaaggaggcggtcactatttgtgtgaatttaaaactac ttacaaggcaaagaagcctgtgaagatgccagggtatcactatgttgaccgcaaactggatgtaaccaatcacaacaaggattacac ttcggttgagcagtgtgaaatttccattgcacgcaaacctgtggtcgcctaataa</FONT><FONT color="orange">TACTAGTAGCGGCCGCTGCAG</FONT></FONT></P><P>3'</P><FIGURE class="fig1"><FIGCAPTION>Fig. 4: Our BioBrick as an important intermediate step</FIGCAPTION></FIGURE></DIV><DIV class="container"><P>We thank our sponsors:</P></DIV></DIV></BODY></HTML>